The nation’s weekly COVID-19 case average is falling at a much faster rate than the number of tests taken, reports The COVID Tracking Project. Since Jan. 12, the seven-day case average has dropped by 63.7 percent, compared to the average testing rate, which has fallen 17.5 percent, according to the Tracking Project. Five more updates: 1. Seven coronavirus variants found across the U.S. have the same mutation, according to a study published Feb. 14 on preprint server medRxiv. The seven growing lineages have evolved a mutation in the same genetic letter. It’s unclear if the variants are more contagious. The study has yet to be…
Author: Praveen Suthrum
VENTURA, Calif., Feb. 15, 2021 /PRNewswire/ — On Jan. 14, 2021, the National Institutes of Health (NIH) reconsidered the anti-parasitic drug Ivermectin as a possible treatment for COVID-19. Ventura Clinical Trials, owned and operated by Dr. Sabine Hazan, is one of the institutions researching Ivermectin and Hydroxychloroquine—with remarkable success.
SMART Medical has now commenced clinical collaboration with NYU Langone Health introducing its newly FDA-cleared G-EYE® 760 Colonoscope series, based on FUJIFILM Corporation’s 510(k) cleared 760 colonoscopes and operating with Fujifilm’s state-of-the-art ELUXEO imaging system RA’ANANA, Israel, Feb. 16, 2021 /PRNewswire/ — SMART Medical Systems Ltd., a developer and manufacturer of innovative endoscopy products, announced the initiation of commercial and clinical effort in the USA, following issuance of a second FDA clearance for its flagship G-EYE® Colonoscope, based on Fujifilm’s 510(k) cleared colonoscopies.
Healio Gastroenterology spoke with Wayne Eskridge, founder and CEO of the Fatty Liver Foundation on the goals the foundation has this year, including increasing screening for liver disease and working around the COVID-19 pandemic. He said nonalcoholic steatohepatitis is more hazardous than diabetes and smoking, and it is not spoken of enough. He said more people need to be made aware of NASH. Eskridge said the foundation’s goal is to screen 1 million people for liver disease over the next few years and to “blunt the epidemic” of liver disease.
Engagement with social media has become a huge part of society, especially in health care, according to a report published in Gastroenterology. Further, the use of social media has increased in the field of gastroenterology over the past 10 years. #GITwitter has become a huge platform for gastroenterologists to share original content, engage in discussion and bring attention to their research. During the COVID-19 pandemic, Twitter use has especially increased.
Dietary patterns and risk of colorectal cancer (CRC) are clearly linked, according to an umbrella review of meta-analyses of prospective observational studies. Overall, 24 (68.6%) of the associations deemed significant pointed to protective effects for certain dietary patterns, including adherence to a healthy diet, a Mediterranean diet, a pesco-vegetarian diet, or a semi-vegetarian diet, reported Nathorn Chaiyakunapruk, PharmD, PhD, of the University of Utah College of Pharmacy in Salt Lake City, and colleagues.
Amazon is a big force in healthcare and has made significant changes in the past 12 months that could affect physician practices and ASCs. The company has launched initiatives to aid the COVID-19 vaccine efforts, make the supply chain more efficient and expand virtual care. Here are seven things to know. 1. Amazon proposed using the company’s operations, IT and communications to help the government distribute COVID-19 vaccines. The company’s CEO of consumer business, Dave Clark, sent a letter to President Joe Biden offering the company’s services. It already teamed up with Seattle-based Virginia Mason to develop a pop-up COVID-19 vaccination site…
Artificial intelligence is a growing area in gastroenterology. It’s something NextServices President Praveen Suthrum predicted as an industry disruptor in his book, Scope Forward, and last year marked several advancements. Here are seven updates since January 2020, starting with the most recent: 1. A partnership reached between Iterative Scopes and Eli Lilly Feb. 11 will explore how AI can improve understanding of inflammatory bowel disease pathophysiology and target identification. Iterative Scopes closed a $5.2 million seed round in January 2020. 2. Chattanooga, Tenn.-based Erlanger Health System started a clinical trial to test an AI device used to increase polyp detection during colonoscopies, according to a Feb. 9 report.
CAMBRIDGE, Mass., Feb. 11, 2021 /PRNewswire/ — Iterative Scopes, a leading Artificial Intelligence in Gastroenterology provider, today unveiled a partnership with Eli Lilly and Company. Despite significant advancements in our understanding of inflammatory bowel disease (IBD) pathophysiology and target identification, progress in IBD research is hampered by variability in the human interpretation of endoscopic severity. Both companies recognize the need to integrate novel methods of interpreting and integrating visual data into the assessment of clinical trial endoscopic endpoints, reducing clinical trial costs, and speeding the assessment of clinical trial data. The initial focus of this collaboration is to work together to advance…
Physicians Thrive released its “Physician Compensation Report 2020,” providing an array of salary information. The financial planning company used information from the Bureau of Labor Statistics Occupational Outlook Handbook, Doximity’s “2019 Physician Compensation Report,” information from salary.com, Merrit Hawkins’ “2019 Review of Physician and Advanced Practitioner Recruiting Incentives,” and Medscape’s “2020 Compensation Overview.” Here are five points related to gastroenterology: 1. Regional median salaries:Eastern: $300,000Midwest: $484,445Southern: $396,872Western: $370,658